5-aminolaevulinic acid (ALA), enhances heme oxygenase (HO)-1 expression and attenuates tubulointerstitial fibrosis and renal apoptosis in chronic cyclosporine nephropathy

Biochem Biophys Res Commun. 2019 Jan 8;508(2):583-589. doi: 10.1016/j.bbrc.2018.11.175. Epub 2018 Dec 2.

Abstract

Background: Cyclosporine-A (CsA) is an immunosuppressant indicated for various immunological diseases; however, it can induce chronic kidney injury. Oxidative stress and apoptosis play a crucial role in CsA-induced nephrotoxicity. The present study evaluated the protective effect of combining 5-aminolaevulinic acid with iron (5-ALA/SFC), a precursor of heme synthesis, to enhance HO-1 activity against CsA-induced chronic nephrotoxicity.

Methods: Mice were divided into three groups: the control group (using olive oil as a vehicle), CsA-only group, and CsA+5-ALA/SFC group. After 28 days, the mice were sacrificed, and blood and kidney samples were collected. In addition to histological and biochemical examination, the mRNA expression of proinflammatory and profibrotic cytokines was assessed.

Results: Renal function in the 5-ALA/SFC treatment group as assessed by the serum creatinine and serum urea nitrogen levels was superior to that of the CsA-only treatment group, demonstrating that 5-ALA/SFC significantly attenuated CsA-induced kidney tissue inflammation, fibrosis, apoptosis, and tubular atrophy, as well as reducing the mRNA level of TNF-α, IL-6, TGF-β1, and iNOS while increasing HO-1.

Conclusion: The activity of 5-ALA/SFC has important implications for clarifying the mechanism of HO-1 activity in CsA-induced nephrotoxicity and may provide a favorable basis for clinical therapy.

Keywords: 5-Aminolaevulinic acid; Apoptosis; Cyclosporine-A; Heme oxygenase (HO)-1; Iron; Oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid
  • Animals
  • Apoptosis / drug effects
  • Atrophy / prevention & control
  • Cyclosporine / adverse effects*
  • Cytokines / genetics
  • Drug Therapy, Combination
  • Fibrosis / prevention & control*
  • Heme Oxygenase-1 / drug effects
  • Heme Oxygenase-1 / metabolism*
  • Inflammation / prevention & control
  • Iron / pharmacology
  • Iron / therapeutic use
  • Levulinic Acids / pharmacology*
  • Levulinic Acids / therapeutic use
  • Mice
  • Nephritis, Interstitial / chemically induced
  • Nephritis, Interstitial / pathology*
  • Nephritis, Interstitial / prevention & control*
  • Oxidative Stress / drug effects
  • RNA, Messenger / analysis

Substances

  • Cytokines
  • Levulinic Acids
  • RNA, Messenger
  • Cyclosporine
  • Iron
  • Heme Oxygenase-1

Supplementary concepts

  • Nephropathy, Chronic Tubulointerstitial